Related Experiment Video
Updated: Sep 2, 2025

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination
Huailin Zhang1, Diana Sanchez Gomez2, Michael Repajic3
1Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Abstract:
Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.
Insights
Limited data exist on recurrent Bell's Palsy following mRNA vaccines. Continued rigorous reporting is essential to accurately determine the incidence of this rare neurological condition after vaccination.
Area of Science:
- Neurology
- Vaccinology
- Epidemiology
Background:
- The COVID-19 pandemic necessitated rapid vaccine development, including mRNA-based vaccines.
- Bell's Palsy, a form of facial paralysis, has been an observed, though rare, adverse event post-vaccination.
- Data on the recurrence of Bell's Palsy after mRNA vaccination remain scarce.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Vaccinations
Cross-reactivity
Myocarditis III: Medical Management

